1. This study was designed to seek evidence for excessive lipid peroxidation in pre-eclamptic women using 8-iso-prostane as a novel bioactive marker of lipid peroxidation in vivo. Plasma free, total and urinary 8-iso-prostane were measured in 20 women with proteinuric pre-eclampsia, and compared with 18 age-and gestation-matched pregnant control subjects, before delivery and at 6 weeks postpartum. 2. Plasma free 8-iso-prostane was significantly elevated in the pre-eclamptic women compared with control subjects before delivery, and fell to control levels post-partum. Conversely, levels in women with normal pregnancy rose post-partum 3. Total plasma 8-iso-prostane levels were not significantly elevated in pre-eclamptic women compared with control subjects during pregnancy, but fell significantly in the pre-eclamptic women postpartum, suggesting that they had relatively higher levels compared with their non-pregnant state. 4. Urinary 8-iso-prostane excretion was significantly lower in the pre-eclamptic women compared with control subjects during pregnancy, suggesting that renal clearance of 8-iso-prostane is impaired in pre-eclampsia. 5. Increased levels of plasma free 8-iso-prostane in pre-eclampsia could be due to an increase in lipid peroxidation, an increase in phospholipase Az activity or a reduction in renal clearance of 8-iso-prostane, or a combination of all three. The potent direct and indirect vasoconstrictor actions of 8-iso-prostane may contribute to the pathogenesis of pre-eclampsia.
INTRODUCTION
Pre-eclampsia is a life-threatening complication of pregnancy. Although the criteria for a diagnosis include hypertension and proteinuria, this condition is a multi-system disorder with impaired hepatic function and activation of the coagulation cascade [l] . Recent studies have shown that pre-eclampsia is also characterized by alterations in levels of both urinary prostacyclin metabolites [2, 31 and plasma endothelin [2, 4, 51, suggesting that endothelial dysfunction characterizes the disorder. The primary events that cause endothelial dysfunction are unknown, but it is likely that once the initial insult occurs the dysfunction is perpetuated by unmodulated platelet activation due to impaired release of the anti-aggregating agents prostacyclin and nitric oxide [l] .
Lipid peroxides and oxygen radicals are highly reactive compounds that are capable of damaging endothelial cells. There is some evidence that the levels of lipid peroxides increase in normal pregnancy and that this is offset by increased levels of antioxidant vitamins [6] . One problem with determining whether or not increased lipid peroxidation occurs in pre-eclampsia has been the lack of good markers of lipid peroxidation in vivo. The two most popular methods, diene conjugation and the thiobarbituric acid test, have been shown to be methodologically flawed, with both methods being subject to non-specific interference in plasma [7] . Recently, a new group of prostaglandin (PG)-like compounds known as iso-prostanes has been discovered. These substances have been shown to be produced in vivo [8, 91 , and are formed independently of cyclo-oxygenase by the actions of free radicals on arachidonic acid [lo] while it is bound to the phospholipid [ll] . The iso-prostanes are subsequently released by the action of phospholipase Az. In plasma, where there is a considerable phospholipid fraction, as well as an active phospholipase Az enzyme, iso-prostanes exist in the free and phospholipid-bound state. Free iso-prostanes are also found in urine [12] . 8-Iso-prostane is the most abundant of the iso-prostane products of free radical oxidation and exerts potent biological activity. 8-Iso-prostane is a potent vasoconstrictor in the lung [13] and kidney, acting via thomboxane Az-like receptors [14] . Recent studies have shown elevated plasma free and total and urinary 8-iso-prostane in smokers, who are known to be under oxidant stress [15] , and elevated levels of plasma total 8-iso-prostane have been demonstrated in non-insulin-dependent diabetic patients compared with control subjects This study aimed to seek further evidence for increased lipid peroxidation in pre-eclampsia by examining total and free 8-iso-prostane in plasma and free 8-iso-prostane in urine in pre-eclampsia and normal pregnancy.
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METHODS
All women gave their informed consent to participate in the study, which was approved by the King Edward Memorial Hospital for Women and the University of Western Australia ethics committees. Two groups of women were recruited for this study. Pre-eclampsia was defined as the development of a blood pressure greater than 140/90 mmHg after 20 weeks gestation, and proteinuria of at least 2 + , in women with no known history of hypertension or renal disease, and whose blood pressure returned to less than 130/90 mmHg within 3 months postpartum. Twenty women with pre-eclampsia were selected after admission to King Edward Memorial Hospital for Women. These women had an average blood pressure on admission of 158 f 5/99 f 2 mmHg, using a standard mercury sphygmomanometer, and urinary protein averaged 2.4 20.6 g/day. A group of 18 normotensive pregnant women acted as controls and were studied in parallel. These women had blood pressures of 104 f 2/60 f 1 mmHg, and were carefully matched for age and gestational age with the pre-eclamptic group. There were 11 primigravid subjects in the pre-eclamptic group, and seven in the normal pregnant group. As there is no good evidence to suggest that the pathophysiology of established pre-eclampsia in primigravids is substantially different from that of multigravids, the analysis was conducted on the combined primigravid and multigravid subject groups. Antihypertensive treatment in the pre-eclamptic group included nifedipine and a-methyldopa; three women were taking aspirin and 11 of the subjects had been given betamethasone within 24 h of having their blood sample taken.
The women were studied on referral to the research nurse before delivery, and at 6 weeks postpartum. At an antenatal visit, all the women answered a questionnaire about their obstetric and medical history, family history of disease and medication usage. Women were excluded from the study if they were diabetic or had a known renal disease.
At each visit, blood pressure was measured four times at 1 min intervals after 5 min seated rest using a manual sphygmomanometer with diastolic blood pressure determined as phase IV Korotkoff sound. A blood sample from the antecubital vein was collected after 10 min seated rest for measurement of plasma total and free 8-iso-prostane as well as plasma endothelin-1, uric acid, creatinine, albumin and a haematological profile. In order to minimize platelet activation an indwelling needle was used, the tourniquet was removed before sampling and blood samples for 8-iso-prostane were collected last. Twenty-four hour urine was collected for measurement of protein, creatinine and urinary 8-iso-prostane. Eighteen of the pre-eclamptic women and seven of the normal pregnant women were delivered by caesarean section. Details of the birth and postnatal complications were obtained from hospital records.
Biochemistry and haematological variables
Plasma electrolytes, creatinine, uric acid, albumin and urea and urinary creatinine and protein were measured using a COVAS-MIRA analyser in the Biochemistry Department at Royal Perth Hospital. A lipid profile including serum cholesterol and triacylglycerols was determined enzymically using Abbott reagents on a COVAS-MIRA analyser in the Department of Biochemistry at Royal Perth Hospital. A full blood screen and leucocyte differential were measured in the Department of Haematology at Royal Perth Hospital using a Coulter Counter. Plasma endothelin-1 was measured by radioimmunoassay after extraction as described previously [2] .
Measurement of plasma total and free 8-iso-prostane and urinary 8-iso-prostane
Blood was collected into ice-cold tubes containing EDTA (1 mg/ml) and reduced glutathione (1 mg/ml), centrifuged at 1500g for 10 min at 4°C and the plasma protected from oxidation by storage at -80"C, with butylated hydroxytoluene, 200 ,ug/ml, added as a chain-breaking antioxidant. Twenty-four hour urine was collected into indomethacin (15 mg) to prevent in v i m formation of prostanoids due to any leucocyte contamination.
Plasma and urinary free 8-iso-prostane
To plasma or urine (0.5 ml), 2000c.p.m. of [3H]thromboxane B2 (TXB2) was added to enable estimation of recovery. As [3H]8-iso-prostane was not commercially available, [3H]TXBz was chosen as a marker for recovery because its cross-reactivity with 8-iso-prostane is very low, and it has extraction properties that are similar to those of 8-iso-prostane. The plasma or urine was then extracted with methanol (2 ml), centrifuged and the supernatant acidified to pH4.0 by the addition of 8ml of phosphate buffer (pH4.0). Each sample was then applied to a C18 Sep-Pak prewashed with methanol (5 ml) and water (5 ml). The samples were washed with 5 ml of water and hexane respectively, and the 8-iso-prostane was eluted with 5 ml of ethyl acetate/ methanol (99:l). The eluate was taken to dryness using a centrifugal evaporator and reconstituted in 1 ml of 0.1 mol/l phosphate buffer, pH 7.4, containing 1% BSA.
Plasma total 8-iso-prostane
The sample extraction was the same except that phospholipid-bound 8-iso-prostane was released by base hydrolysis with 1ml of 1 mol/l KOH in methanol for 30 min at 45°C before the acidification step.
Enzyme immunoassay of 8-iso-prostane
The samples were assayed with tracer standards and antiserum provided by Cayman Chemical Co. Fifty microlitres of sample were assayed in duplicate with one serial dilution. The antibodies and components used in this enzyme immunoassay have previously been validated for the measurement of plasma and urinary 8-iso-prostane using gas GC-MS [17] . The sample and duplicate standards of 0, 3.9, 7.8, 15.6, 31.3, 62.5, 125, 250 and 500 pg/ml were incubated in a 96-well plate with 50 p1 of 8-iso-prostane acetylcholinesterase tracer and 50 pl of 8-iso-prostane antiserum for 18 h at room temperature. After washing with a wash buffer containing 10 mmol/l potassium phosphate (pH 7.4) the plate was developed by the addition of 200 pl of Ellmans reagent and after 60min was read in a Biorad microplate reader at 450nm. The antiserum crossreacted as follows: 8-iso-prostane, 100%; 8-iso-PGFsa, 20.55%; 8-iso-PGEz and 8-iso-PGE1, PGE1, 0.39%; TXBz, 0.08%; 6-keto-PGFla, 0.14%. The within-assay variation was 6%, and the between-assay variation was 10%. To reduce the assay variation, samples from matched pairs at each visit were run in the same assay. <2%; PGFa, 0.38%; PGFIa, 0.71%; PGF3a, 0.66%;
STATISTICAL ANALYSIS
Results are expressed as means f SEM. Betweengroup comparisons before delivery were carried out using unpaired t-tests or, where the data was not normally distributed, a Mann-Whitney test. Multiple regression analysis was used to formulate models that best explained the variance in urinary 8-iso-prostane in the pre-eclamptic group before delivery.
RESULTS

Biochemical and haematological variables
The characteristics of the two groups are shown in Table 1 . The two groups were well matched with respect to age and gestation at sampling but the women with pre-eclampsia had significantly elevated blood pressure, plasma uric acid levels and proteinuria compared with their normotensive control subjects. Gestation at delivery was considerably shorter in the pre-eclamptic group and the birthweight of the infants was significantly less. Creatinine clearance was significantly lower (P < 0.01) in the pre-eclamptic group before delivery, showing that this group had reduced renal function (Table  2) . Renal function was similar between the groups by 6 weeks post-partum. Plasma endothelin-1 was significantly elevated in the pre-eclamptic group before pregnancy: 5.62 k 1.06 pg/ml compared with 3.06 f 0.41 pg/ml in normal pregnancy ( Table 2 ). The increase in plasma endothelin-1 in the pre-eclamptic group was not correlated with creatinine clearance. After delivery, the two groups had similar levels of plasma endothelin-1. The lipid profile with respect to total cholesterol was similar between the two groups before delivery, with both groups having similarly raised cholesterol compared with 6 weeks post-partum (Table 2) . Plasma triacylglycerols were, however, significantly elevated in the pre-eclamptic patients compared with normal pregnancy (Table 2) . A haematological profile showed that haematocrit was not different between the groups before delivery, but platelet count was significantly lower and neutrophil count was significantly higher in the pre-eclamptic group before Table 2 ). The differences in haematological profile had disappeared by 6 weeks postpartum.
Plasma free 8-iso-prostane
The levels of plasma free 8-iso-prostane were significantly higher in the pre-eclamptic group before delivery (72.2 k 16.3 pg/ml compared with 33.5 & 7.2 pg/ml in the control group) (P < 0.05) (Fig.  1 ). These differences could not be explained by changes in haematocrit. After delivery, the levels fell significantly in the pre-eclamptic group and rose in the control group, so that at 6 weeks post-partum there were no differences in plasma free 8-iso-prostane between the two groups (Fig. 1) .
Plasma total 8-iso-prostane
During pregnancy, the levels of total 8-iso-prostane in plasma from pre-eclamptic women (152 k 28.8 pg/ml) showed a non-significant trend to be higher than those in normal pregnancy (120.7f 12.9 pg/ml) (Fig. 1) . After delivery, there were no differences in plasma total 8-iso-prostane between the two groups (Fig. 1) . Although the absolute levels of total 8-iso-prostane were not significantly higher in the pre-eclamptic group before delivery, there was a significant fall post-partum ( -51.2 f 20.4 pg/ml compared with 1.3 f 20.3 pg/ml in the normal pregnant group) (P = 0.05) (Fig. 2) .
In neither the pre-eclamptic group nor the normal pregnant group were correlations found between the levels of free or esterified 8-iso-prostane and systolic blood pressure, uric acid, plasma creatinine, plasma cholesterol, plasma triacylglycerols, platelet or neutrophi1 count, haematocrit or plasma endothelin-1.
Urinary 8-iso-prostane
In contrast to plasma 8-iso-prostane7 urinary 8-iso-prostane was significantly reduced in the pre-eclamptic group (1052 f 130 ng/24 h) compared with normal pregnancy (1620 & 127 ng/24 h) (Fig. 3) . After delivery, the groups were not different with respect to urinary 8-iso-prostane. In the normal pregnant group, the levels of urinary 8-iso-prostane were not correlated with systolic blood pressure, uric acid, plasma creatinine or creatinine clearance, plasma cholesterol, plasma triacylglycerols or plasma endothelin-1. However, in the pre-eclamptic group, urinary 8-iso-prostane was positively correlated with creatinine clearance (r = 0.66) and plasma endothelin-1 (r = 0.42), and negatively correlated with plasma uric acid ( -r = 0.42). In the pre-eclamptic group multiple regression analysis was conducted with urinary 8-iso-prostane as the dependent variable. The model of best fit in the pre-eclamptic group contained a positive relationship with plasma creatinine and a positive relationship with plasma endothelin-1 and accounted for 66% of the variance in urinary 8-iso-prostane ( Table  3) .
DISCUSSION
These results show that women with pre-eclampsia have elevated free but not total cb --150-I--200-2 plasma 8-iso-prostane and diminished urinary 8-iso-prostane excretion compared with normal pregnant women. Two important questions arise from these results. Firstly, what causes the increase in plasma free 8-iso-prostane and secondly, are the levels of 8-iso-prostane generated likely to contribute to the pathogenesis of pre-eclampsia? It is unlikely that increased plasma free 8-iso-prostane in pre-eclampsia is due to haemoconcentration, as the differences in plasma free 8-iso-prostane levels in the two groups cannot be explained by differences in haematocrit. Therefore, the most likely mechanisms causing plasma free 8-iso-prostane to be elevated in clearance, or a combination of the three. Lipid peroxidation could contribute to elevated plasma free 8-iso-prostane; however, studies of copperinduced low-density lipoprotein oxidation in vitro [18, 191 and studies in smokers who are known to be under oxidant stress [15] show that increased levels of esterified 8-iso-prostane, and therefore total 8-iso-prostane, normally accompany oxidation. Although the absolute levels of total 8-iso-prostane were not significantly elevated in pre-eclampsia, there was a significantly greater fall in levels in the pre-eclamptic group at 6 weeks post-partum compared with the normal pregnant group, suggesting a relative increase in total 8-iso-prostane and therefore lipid peroxidation in pre-eclampsia compared with their non-pregnant state. It has been suggested that a minor contribution to 8-iso-prostane levels could be made by platelet cyclo-oxygenase during platelet aggregation using collagen or thrombin as agents [20] . In our study, every effort was made to minimize platelet activa- tion in vitro by standardizing the protocol for blood collection. Therefore, we feel that any contribution to plasma free 8-iso-prostane levels by platelet activation during sampling is likely to be small. An increase in phospholipase A2 activity may have contributed to elevated plasma free 8-iso-prostane levels in pre-eclampsia. Although not measured in our study, type I1 phospholipase A2 which exists in secretable and intracellular forms in endothelial cells, neutrophils, platelets, macrophages and hepatocytes , has been shown to be elevated in pre-eclampsia in two studies [24, 251. This could contribute to elevated plasma free 8-iso-prostane in the absence of changes in total 8-iso-prostane. Betamethasone, frequently used in women with pre-eclampsia, might be expected to decrease levels of free 8-iso-prostane because of its actions on phospholipase Az. However, when we examined the levels of total and free 8-isoprostane in the pre-eclamptic women who had not taken betamethasone we found the levels to be similar to the whole group.
Urinary excretion of 8-iso-prostane is significantly reduced in patients with pre-eclampsia, suggesting that impaired renal clearance of 8-iso-prostane could contribute to the elevated free plasma levels of 8-iso-prostane. The post-partum fall in levels of Table 3 . Regression model for urinary 8-iso-prostane in pre
Dependent variable
Independent variables urinary 8-iso-prostane in the control group suggests that the excretion of this lipid peroxidation product is significantly enhanced in normal pregnancy due to more efficient renal clearance of the unesterified 8-iso-prostane by the kidney. Supporting this argument are the lower plasma free 8-iso-prostane levels in normal pregnant women before delivery, compared with the non-pregnant state, which cannot be explained by differences in haematocrit. Therefore, impaired renal function in our pre-eclamptic women may also have contributed to increased plasma free 8-iso-prostane levels during pregnancy. Renal function is clearly an important factor determining the levels of urinary 8-iso-prostane as regression analysis showed that the levels of 8-iso-prostane in the urine of pre-eclamptic women were positively correlated with creatinine clearance. The question also arises as to whether the increased plasma free iso-prostane levels contribute directly to the pathogenesis of pre-eclampsia. 8-Iso-prostane is a potent vasoconstrictor, particularly in the renal vasculature, and is known to act on platelet aggregation as a partial agonist inducing platelet shape change [26] . Although the levels of plasma free 8-iso-prostane measured by us are considerably lower than those that cause vasoconstriction in vitro, it is possible that neutrophil activation and subsequent local release of free radicals in the placental and maternal circulation produce concentrations high enough to have a biological effect. In addition, recent work by Fukunaga et al. [27] has shown that 8-iso-prostane is capable of stimulating endothelin-1 secretion from bovine aortic endothelial cells in vitro. In view of the fact that plasma endothelin-1 is elevated in pre-eclampsia in a number of studies [2, 4, 5, 28, 291 including this one, any elevation of 8-iso-prostane could potentially affect vasoconstriction, both directly and indirectly via endothelin-1-mediated vasoconstriction. This is one of the first studies to use enzyme immunoassay for measurement of 8-iso-prostane. Previous studies have used GC-MS for identification of free and esterified 8-iso-prostane.
We believe that our assay is comparable to the GC-MS methods used previously for two reasons. Firstly, an enzyme immunoassay using the same antibodies and methodology as described here has been validated by GC-MS for urinary 8-iso-prostane [17] . Secondly, the average level of plasma free 8-iso-prostane in the non-pregnant state in our study using the enzyme immunoassay (155 30 pmolfl) is comparable with levels in the normal subjects examined by Morrow et al. [15] using GC-MS (103 k 19 pmol/l). In addition, the levels of urinary 8-iso-prostane in the non-pregnant state in our study (1.05 k 0.1 ng/mg creatinine) were comparable to those of healthy women examined by Awad et al. [9] using GC-MS (1.7 1 ng/mg creatinine). These results suggest that it is unlikely that we are measuring other lipid-like substances that may interfere with the 8-iso-prostane antibody.
Previous studies have suggested that normal pregnancy is associated with elevated or unchanged maternal levels of lipid peroxides [6, 30, 311; however, the methods employed were spectrophotometric and therefore prone to non-specific interference. Our results provide no evidence for increased maternal lipid peroxides in normal pregnancy, as assessed by 8-iso-prostane levels. In normal control subjects, levels of total iso-prostane were similar in the pregnant and post-partum state, while free iso-prostane levels were lower during pregnancy than post-partum, presumably due to increased renal clearance.
In conclusion, pregnancy causes a greater elevation in lipid peroxidation products measured as free and total 8-iso-prostane in pre-eclamptic women compared with controls. Elevations in plasma free 8-iso-prostane levels could also be due to reduced renal clearance of 8-iso-prostane by the kidney, and increased phospholipase AZ activity. The finding of elevated plasma free 8-iso-prostane in pre-eclampsia may be important, regardless of the mechanism of formation, as 8-iso-prostane is a potent vasoconstrictor, especially in the renal vasculature, and may contribute to renal and/or placental vasoconstriction in pre-eclampsia.
